Association between immunohistochemical markers and response after neoadjuvant chemotherapy in advanced breast cancer

被引:0
|
作者
Lee, H. [1 ]
Lee, O. [1 ]
Son, S. [1 ]
Woo, C. G. [1 ]
机构
[1] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Cheongju, South Korea
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
E-PS-02-05
引用
收藏
页码:S197 / S197
页数:1
相关论文
共 50 条
  • [21] Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers
    Haeberle, Lothar
    Erber, Ramona
    Gass, Paul
    Hein, Alexander
    Niklos, Melitta
    Volz, Bernhard
    Hack, Carolin C.
    Schulz-Wendtland, Ruediger
    Huebner, Hanna
    Goossens, Chloe
    Christgen, Matthias
    Doerk, Thilo
    Park-Simon, Tjoung-Won
    Schneeweiss, Andreas
    Untch, Michael
    Nekljudova, Valentina
    Loibl, Sibylle
    Hartmann, Arndt
    Beckmann, Matthias W.
    Fasching, Peter A.
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [22] Association of stromal cell gene expression with response to neoadjuvant chemotherapy in locally advanced breast cancer
    da Costa Vieira, Rene Aloisio
    Zucca Matthes, Angelo Gustavo
    Hirata Katayama, Maria Lucia
    Andrade, Victor Piana
    Roela, Rosimeire Aparecida
    Lima, Luiz Guilherme C. A.
    Maistro, Simone
    Brentani, Maria Mitzi
    Koike Folgueira, Maria A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] Association of T-cadherin levels with the response to neoadjuvant chemotherapy in locally advanced breast cancer
    Kong, Dedi
    Wang, Mei-Hong
    Yang, Jie
    Li, Liang
    ONCOTARGET, 2017, 8 (08) : 13747 - 13753
  • [24] Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer
    Yang, Xu
    Cai, Geng-Xi
    Han, Bo-Wei
    Guo, Zhi-Wei
    Wu, Ying-Song
    Lyu, Xiaoming
    Huang, Li-Min
    Zhang, Yuan-Bin
    Li, Xin
    Ye, Guo-Lin
    Yang, Xue-Xi
    NPJ BREAST CANCER, 2021, 7 (01)
  • [25] Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer
    Xu Yang
    Geng-Xi Cai
    Bo-Wei Han
    Zhi-Wei Guo
    Ying-Song Wu
    Xiaoming Lyu
    Li-Min Huang
    Yuan-Bin Zhang
    Xin Li
    Guo-Lin Ye
    Xue-Xi Yang
    npj Breast Cancer, 7
  • [26] Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer
    Yildirim, Emine
    Bektas, Sibel
    Yetis, Firat
    Yildiz, Eren Ozan
    Ozdemir, Muhammed
    Komut, Neslihan
    Calik, Mustafa
    Er, Ahmet Muzaffer
    ANNALI ITALIANI DI CHIRURGIA, 2023, 94 (04) : 336 - 345
  • [27] Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
    I F Faneyte
    J G Schrama
    J L Peterse
    P L Remijnse
    S Rodenhuis
    M J van de Vijver
    British Journal of Cancer, 2003, 88 : 406 - 412
  • [28] Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
    Faneyte, IF
    Schrama, JG
    Peterse, JL
    Remijnse, PL
    Rodenhuis, S
    van der Vijver, MJ
    BRITISH JOURNAL OF CANCER, 2003, 88 (03) : 406 - 412
  • [29] Serum proteins as predictive markers of the response to neoadjuvant chemotherapy for breast cancer
    Steenbuck, Ines Derya
    Cosenza, Miguel
    Froehlich, Klemens
    Mayer, Bettina
    Werner, Tilman
    Jaeger, Markus
    Weiss, Daniela
    Noething, Claudia
    Schilling, Oliver
    Erbes, Thalia
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 14 - 14
  • [30] Prognostic value of pathologic complete response and the alteration of breast cancer immunohistochemical biomarkers after neoadjuvant chemotherapy
    Shuai, Yanjie
    Ma, Li
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (01) : 29 - 33